Karin Hock

485 total citations
22 papers, 360 citations indexed

About

Karin Hock is a scholar working on Immunology, Hematology and Transplantation. According to data from OpenAlex, Karin Hock has authored 22 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 6 papers in Hematology and 5 papers in Transplantation. Recurrent topics in Karin Hock's work include T-cell and B-cell Immunology (10 papers), Immune Cell Function and Interaction (9 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Karin Hock is often cited by papers focused on T-cell and B-cell Immunology (10 papers), Immune Cell Function and Interaction (9 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Karin Hock collaborates with scholars based in Austria, United States and Germany. Karin Hock's co-authors include Thomas Wekerle, Nina Pilat, B. Mahr, Christoph Schwarz, Lukas Unger, Fritz Wrba, Ulrike Baranyi, Rupert Oberhuber, Stefan G. Tullius and Klaus Aumayr and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Karin Hock

21 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Hock Austria 12 173 134 80 70 54 22 360
Meredith Chittenden United States 10 273 1.6× 151 1.1× 108 1.4× 107 1.5× 52 1.0× 12 417
Marieta Chan Singapore 7 193 1.1× 135 1.0× 78 1.0× 74 1.1× 125 2.3× 17 372
Emeline Masson France 8 199 1.2× 73 0.5× 72 0.9× 136 1.9× 40 0.7× 11 349
Jessica Voss United States 6 190 1.1× 69 0.5× 43 0.5× 36 0.5× 67 1.2× 9 281
Carmen Botella Spain 14 152 0.9× 137 1.0× 112 1.4× 20 0.3× 21 0.4× 29 327
Patrick Miqueu France 7 208 1.2× 69 0.5× 45 0.6× 40 0.6× 62 1.1× 10 304
Marrie J. Kardol Netherlands 13 330 1.9× 143 1.1× 117 1.5× 61 0.9× 39 0.7× 19 487
Angus W. Thomson United States 10 375 2.2× 151 1.1× 198 2.5× 64 0.9× 55 1.0× 15 639
S Ode-Hakim Germany 8 181 1.0× 66 0.5× 51 0.6× 16 0.2× 46 0.9× 11 347
Francisco Boix Spain 14 176 1.0× 238 1.8× 180 2.3× 22 0.3× 15 0.3× 38 413

Countries citing papers authored by Karin Hock

Since Specialization
Citations

This map shows the geographic impact of Karin Hock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Hock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Hock more than expected).

Fields of papers citing papers by Karin Hock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Hock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Hock. The network helps show where Karin Hock may publish in the future.

Co-authorship network of co-authors of Karin Hock

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Hock. A scholar is included among the top collaborators of Karin Hock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Hock. Karin Hock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Singer, Christian F., Leopold Öhler, Daniel Egle, et al.. (2019). REACHAUT: First-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC) in the real-world setting.. Journal of Clinical Oncology. 37(15_suppl). e12527–e12527. 3 indexed citations
3.
Mahr, B., et al.. (2018). Hybrid resistance to parental bone marrow grafts in nonlethally irradiated mice. American Journal of Transplantation. 19(2). 591–596. 10 indexed citations
4.
Mahr, B., Nina Pilat, Christoph Schwarz, et al.. (2017). Regulatory T Cells Promote Natural Killer Cell Education in Mixed Chimeras. American Journal of Transplantation. 17(12). 3049–3059. 16 indexed citations
5.
Baranyi, Ulrike, Karin Hock, B. Mahr, et al.. (2016). Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy. EBioMedicine. 7. 230–239. 13 indexed citations
6.
Schwarz, Christoph, Lukas Unger, B. Mahr, et al.. (2016). The Immunosuppressive Effect of CTLA4 Immunoglobulin Is Dependent on Regulatory T Cells at Low But Not High Doses. American Journal of Transplantation. 16(12). 3404–3415. 27 indexed citations
7.
Hock, Karin, Johannes Laengle, И. Л. Кузнецова, et al.. (2016). Oncolytic influenza A virus expressing interleukin-15 decreases tumor growth in vivo. Surgery. 161(3). 735–746. 33 indexed citations
8.
Mahr, B., Lukas Unger, Karin Hock, et al.. (2016). IL-2 / α-IL-2 Complex Treatment Cannot Be Substituted for the Adoptive Transfer of Regulatory T cells to Promote Bone Marrow Engraftment. PLoS ONE. 11(1). e0146245–e0146245. 15 indexed citations
9.
Pilat, Nina, B. Mahr, Lukas Unger, et al.. (2016). Incomplete clonal deletion as prerequisite for tissue-specific minor antigen tolerization. JCI Insight. 1(7). e85911–e85911. 15 indexed citations
10.
Pilat, Nina, Christoph Klaus, Christoph Schwarz, et al.. (2015). Rapamycin and CTLA4Ig Synergize to Induce Stable Mixed Chimerism Without the Need for CD40 Blockade. American Journal of Transplantation. 15(6). 1568–1579. 22 indexed citations
11.
Hock, Karin, B. Mahr, Christoph Schwarz, & Thomas Wekerle. (2015). Deletional and regulatory mechanisms coalesce to drive transplantation tolerance through mixed chimerism. European Journal of Immunology. 45(9). 2470–2479. 8 indexed citations
12.
Baranyi, Ulrike, Nina Pilat, Karin Hock, et al.. (2015). Anti‐OX40L alone or in combination with anti‐CD40L and CTLA4Ig does not inhibit the humoral and cellular response to a major grass pollen allergen. Clinical & Experimental Allergy. 46(2). 354–364.
13.
Hock, Karin, Nina Pilat, Ulrike Baranyi, et al.. (2014). Donor CD4 T Cells Trigger Costimulation Blockade-Resistant Donor Bone Marrow Rejection Through Bystander Activation Requiring IL-6. American Journal of Transplantation. 14(9). 2011–2022. 8 indexed citations
14.
Hock, Karin, et al.. (2013). Immunosenescence Does Not Abrogate Engraftment of Murine Allogeneic Bone Marrow. Transplantation. 95(12). 1431–1438. 7 indexed citations
15.
Pilat, Nina, B. Mahr, Christoph Schwarz, et al.. (2013). T-regulatory cell treatment prevents chronic rejection of heart allografts in a murine mixed chimerism model. The Journal of Heart and Lung Transplantation. 33(4). 429–437. 46 indexed citations
16.
Baranyi, Ulrike, Nina Pilat, Karin Hock, et al.. (2013). Engraftment of retrovirally transduced Bet v 1-GFP expressing bone marrow cells leads to allergen-specific tolerance. Immunobiology. 218(9). 1139–1146. 5 indexed citations
17.
Baranyi, Ulrike, Karin Hock, Nina Pilat, et al.. (2013). The site of allergen expression in hematopoietic cells determines the degree and quality of tolerance induced through molecular chimerism. European Journal of Immunology. 43(9). 2451–2460. 7 indexed citations
18.
Heinbokel, Timm, Karin Hock, Guangxiang Liu, et al.. (2012). Impact of immunosenescence on transplant outcome. Transplant International. 26(3). 242–253. 35 indexed citations
19.
Ramsey, Haley E., Nina Pilat, Karin Hock, et al.. (2012). Anti-LFA-1 or rapamycin overcome costimulation blockade-resistant rejection in sensitized bone marrow recipients. Transplant International. 26(2). 206–218. 11 indexed citations
20.
Pilat, Nina, Karin Hock, & Thomas Wekerle. (2011). Mixed chimerism through donor bone marrow transplantation. Current Opinion in Organ Transplantation. 17(1). 63–70. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026